Additionally, the transwell assay revealed a consistent decrease in migration ability in SNB-19 cells after SCNN1B knockdown (Figures 10C, D; #1, P<0.001; #2, P<0.001), indicating the crucial role of SCNN1B in gliomas. This evidence concerns the gene SCNN1B and central nervous system cancer.